{
    "organizations": [],
    "uuid": "f755df38c5cc412caa23cec315c8284dc3f7a568",
    "author": "",
    "url": "https://www.reuters.com/article/brief-labcorp-reports-q1-earnings-per-sh/brief-labcorp-reports-q1-earnings-per-share-1-67-idUSASC09X9D",
    "ord_in_thread": 0,
    "title": "BRIEF-LabCorp Reports Q1 Earnings Per Share $1.67",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 25 (Reuters) - Laboratory Corporation of America Holdings:\n* LABCORP ANNOUNCES STRONG 2018 FIRST QUARTER RESULTS AND UPDATES 2018 GUIDANCE\n* Q1 EARNINGS PER SHARE $1.67 * Q1 REVENUE $2.85 BILLION VERSUS I/B/E/S VIEW $2.77 BILLION\n* SEES FY 2018 ADJUSTED EARNINGS PER SHARE $11.30 TO $11.70\n* Q1 ADJUSTED EARNINGS PER SHARE $2.78 * Q1 EARNINGS PER SHARE VIEW $2.63 — THOMSON REUTERS I/B/E/S\n* BOARD AUTHORIZED AN INCREASE IN COMPANY’S TOTAL SHARE REPURCHASE PROGRAM TO A TOTAL OF $1.0 BILLION\n* 2018 FREE CASH FLOW GUIDANCE OF $1.1 BILLION TO $1.2 BILLION, UNCHANGED FROM PRIOR GUIDANCE\n* 2018 ADJUSTED EPS GUIDANCE OF $11.30 TO $11.70, UNCHANGED FROM PRIOR GUIDANCE\n* 2018 ADJUSTED EPS GUIDANCE NOW INCLUDES PROJECTED NEGATIVE IMPACT FROM ASC 606 OF ABOUT $0.20 TO $0.30 PER SHARE FOR FULL YEAR 2018\n* EFFECTIVE JANUARY 1, 2018, COMPANY ADOPTED FASB-ISSUED CONVERGED STANDARD ON REVENUE RECOGNITION (ASC 606)\n* SEES 2018 REVENUE GROWTH OF 10.0% TO 12.0% OVER 2017 REVENUE OF $10.31 BILLION\n* BACKLOG AT END OF QUARTER WAS $9.17 BILLION FOR COVANCE DRUG DEVELOPMENT Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-25T14:11:00.000+03:00",
    "crawled": "2018-04-25T14:24:30.004+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "laboratory",
        "corporation",
        "america",
        "holding",
        "labcorp",
        "announces",
        "strong",
        "first",
        "quarter",
        "result",
        "update",
        "guidance",
        "q1",
        "earnings",
        "per",
        "share",
        "q1",
        "revenue",
        "billion",
        "versus",
        "view",
        "billion",
        "see",
        "fy",
        "adjusted",
        "earnings",
        "per",
        "share",
        "q1",
        "adjusted",
        "earnings",
        "per",
        "share",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "board",
        "authorized",
        "increase",
        "company",
        "total",
        "share",
        "repurchase",
        "program",
        "total",
        "billion",
        "free",
        "cash",
        "flow",
        "guidance",
        "billion",
        "billion",
        "unchanged",
        "prior",
        "guidance",
        "adjusted",
        "eps",
        "guidance",
        "unchanged",
        "prior",
        "guidance",
        "adjusted",
        "eps",
        "guidance",
        "includes",
        "projected",
        "negative",
        "impact",
        "asc",
        "per",
        "share",
        "full",
        "year",
        "effective",
        "january",
        "company",
        "adopted",
        "converged",
        "standard",
        "revenue",
        "recognition",
        "asc",
        "see",
        "revenue",
        "growth",
        "revenue",
        "billion",
        "backlog",
        "end",
        "quarter",
        "billion",
        "covance",
        "drug",
        "development",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}